INS and Obesity: Excessive GPX1 activity may be detrimental to T2D and obesity, as demonstrated by the positive association between the overexpression of GPx1 and the impaired glucose clearance, hyperinsulinemia, hyperglycemia, and reduced insulin signaling in a mouse model [162].